Jon Hammack

Partner

EMAIL

jon.hammack@solomonpartners.com

PHONE

212-508-1609

Jon Hammack is a Partner and serves as Head of Healthcare, focused on medical devices and outsourced services. He joined the firm in 2021.

Jon has over 20 years of healthcare investment banking experience and specializes in advising clients in the medical device and outsourced services sectors. He has advised boards of directors and special committees as well as companies on a broad range of transactions, including mergers, acquisitions, divestitures, leveraged buyouts, restructurings and capital raising solutions.

Prior to joining Solomon Partners, Jon was a Managing Director at Moelis & Company where he spent eight years leading and expanding the firm’s medical device and outsourced services sectors. Before Moelis, Jon was a Managing Director and Head of Medical Technology at Morgan Stanley.

Over the past two decades, Jon has advised on numerous key healthcare transactions with total transaction value over $100 billion.

Select transactions include:

  • Acquisition of ASP Global by Platinum Equity
  • Sale of TIDI Products to TJC
  • Acquisition of CoreLink by Zavation
  • Growth Investment in Nox Health by Vestar Capital
  • Acquisition of Magellan Rx by Prime Therapeutics
  • Sale of Zavation Medical to Gemspring
  • Sale of Northfield Medical to Agiliti
  • Sale of Clinical Innovations to LABORIE Medical
  • Sale of Hu-Friedy to Cantel Medical
  • Sale of Invuity to Stryker
  • Sale of Zest Dental to BC Partners
  • Sale of Argon Medical to Weigao
  • Acquisition of MIS Implants by Dentsply Sirona
  • Merger of Dentsply and Sirona

Jon holds a BS from the University of Washington and an MBA from the Kellogg School of Management at Northwestern University.

Select Recent Transactions

Served as financial advisor to Guerbet on the sale of its Accurate Medical microcatheter assets to Argon Medical
January 2025
Served as financial advisor to Platinum Equity on its acquisition of ASP Global
August 2024
Served as financial advisor to Prime Therapeutics on its strategic alliance with and minority investment in Capital Rx
March 2024
Served as financial advisor to TIDI Products on its sale to TJC
December 2023
Served as financial advisor to Zavation on its acquisition of CoreLink
June 2023
Served as the exclusive financial advisor and placement agent to Prime Therapeutics on its acquisition of Magellan Rx
December 2022
Served as financial advisor to ProSomnus on its merger with Lakeshore Acquisition I SPAC
December 2022
Served as financial advisor to Vestar Capital on its strategic growth investment in Nox Health
November 2022

Latest Insights

Navigating Opportunities and Challenges in Today’s Healthcare M&A Market

Subscribe Episode Description Solomon’s Head of Healthcare Jon Hammack and Partner Jon Pritti explore the dynamics shaping today’s healthcare M&A…

Industry Q&A – Marc Cooper with Jon Hammack

Head of Healthcare, Jon Hammack sat with CEO Marc Cooper to discuss the latest in the healthcare sector. Click below…

Healthcare Technology & Tech-Enabled Services – 2022 Annual Review

Friends and Colleagues, With another year of M&A and financings in the books, we’re pleased to provide you with our…